Concerning iodine-refractory DTC, the utility of the tumor-specific marker Tg for clinical management is limited, as these tumors are characterized by a variable degree of dedifferentiation with decreased expression of the thyroid handling genes [97], including Tg. Here, TG is linked to neoplasm.